[Genotype 1 superresponder treat for only 24 weeks].
出版信息
MMW Fortschr Med. 2005 Dec 15;147(51-52):69.
PMID:16402717
Abstract
摘要
相似文献
1
[Genotype 1 superresponder treat for only 24 weeks].
MMW Fortschr Med. 2005 Dec 15;147(51-52):69.
2
Interferon for hepatitis C patients with psychiatric disorders.
Am J Psychiatry. 2004 Dec;161(12):2331-2; author reply 2332-4. doi: 10.1176/appi.ajp.161.12.2331.
3
Treatment duration for genotypes 2 and 3: still confusing after all these years.
J Clin Gastroenterol. 2010 Sep;44(8):527-8. doi: 10.1097/MCG.0b013e3181e0b1ce.
4
A change of peginterferon may permit continuation of antiviral therapy in hepatitis C virus-infected patients with interstitial pneumonitis.
Liver Int. 2010 Nov;30(10):1552-4. doi: 10.1111/j.1478-3231.2010.02297.x.
5
[Antiviral therapy of patients with chronic hepatitis C with normal level of aminotransferases].
Eksp Klin Gastroenterol. 2007(4):146-52.
6
[Peginterferon-alfa-2b or -alfa-2a and ribavirin combined treatment in hepatitis C infection].
Orv Hetil. 2010 Feb 14;151(7):271-3. doi: 10.1556/OH.2010.28801.
7
Predicting treatment outcome following 24 weeks peginterferon alpha-2a/ribavirin therapy in patients infected with HCV genotype 1: utility of HCV-RNA at day 0, day 22, day 29, and week 6.
Hepatology. 2007 Jan;45(1):258-9. doi: 10.1002/hep.21505.
8
Pegylated IFN-alpha2a and ribavirin in the treatment of hepatitis C.
Expert Rev Anti Infect Ther. 2009 Oct;7(8):925-35. doi: 10.1586/eri.09.70.
9
Hepatitis C treatment, HAART and side effects.
TreatmentUpdate. 2001 Nov-Dec;13(7):7-8.
10
Peginterferon and ribavirin for chronic hepatitis C.
N Engl J Med. 2006 Dec 7;355(23):2444-51. doi: 10.1056/NEJMct061675.
Zotero 插件